Overview

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Status:
Completed

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

This is a pilot study to examine if the novel treatment regimen maraviroc plus boosted atazanavir can be expected to be safe and efficacious in treatment naive HIV infected patients. Based on the results from this study, a confirmatory phase 3 study may be conducted.

Phase:

Phase 2

Details

Lead Sponsor:

ViiV Healthcare

Collaborator:

Pfizer

Treatments:

Atazanavir Sulfate
Darunavir
Emtricitabine
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Lopinavir
Maraviroc
Protease Inhibitors
Ritonavir
Tenofovir